Myofascial Points Treatment With Focused Extracorporeal Shock Waves (ESW) (ESW)
Plantar Fasciitis, Myofascial Trigger Point Pain, Foot Injury
About this trial
This is an interventional treatment trial for Plantar Fasciitis
Eligibility Criteria
Inclusion Criteria:
- ≥ 18 years of age,
- the presence of heel pain ≥ 3 months duration unresponsive to first-choice conservative treatments (non-steroidal anti-inflammatory and/or other analgesic drugs, exercise program, insoles),
- specialist diagnosis of plantar fasciitis confirmed with clinical examination,
- pain intensity ≥ 5 at the Visual Analog Scale (VAS)
Exclusion Criteria:
- previous ankle/foot fracture or surgery,
- previous ankle/foot infections,
- neurological deficits of the lower limbs,
- diagnosis or suspect of fibromyalgia,
- local steroid injection within the previous 3 months,
- diabetes mellitus,
- vascular diseases
Sites / Locations
- Department of Neurosciences, Physical and Rehabilitation Unit, University of Padova
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Lower limb myofascial trigger points f-ESWT group
Plantar fascia insertion f-ESWT group
3 total sessions, one per week, of focused extracorporeal shockwave treatment with a frequency of 5 Hz, an energy flux density of 0.05-0.167 mJ (millijoule)/mm2 administered on 3 or 4 myofascial points (identified based on Fascial Manipulation principles), 1500 shocks per point.
3 total sessions, one per week, of focused extracorporeal shockwave treatment, with a frequency of 5 Hz, an energy flux density of 0.32 mJ(millijoule)/mm2, for a total of 2000 shocks administered on the area of the painful heel on the medial calcaneal tubercle.